Literature DB >> 8704069

Clozapine-induced myoclonus and generalized seizures.

M Sajatovic1, H Y Meltzer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8704069     DOI: 10.1016/0006-3223(95)00499-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  6 in total

1.  Rapid Clozapine Titration in Patients with Treatment Refractory Schizophrenia.

Authors:  Cana Aksoy Poyraz; Armağan Özdemir; Nazife Gamze Usta Sağlam; Şenol Turan; Burç Çağrı Poyraz; Nesrin Tomruk; Alaattin Duran
Journal:  Psychiatr Q       Date:  2016-06

Review 2.  Seizure associated with clozapine: incidence, etiology, and management.

Authors:  Andrew M Williams; Susie H Park
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

Review 3.  Effectiveness of ultra-rapid dose titration of clozapine for treatment-resistant bipolar mania: case series.

Authors:  Cana Aksoy Poyraz; Şenol Turan; Ömer Faruk Demirel; Nazife Gamze Usta Sağlam; Nazım Yıldız; Alaattin Duran
Journal:  Ther Adv Psychopharmacol       Date:  2015-08

4.  Clozapine-related EEG changes and seizures: dose and plasma-level relationships.

Authors:  Seema Varma; Delia Bishara; Frank M C Besag; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2011-04

Review 5.  Clozapine-induced myoclonus: a case report and review of the literature.

Authors:  Ian J Osborne; Ronan J McIvor
Journal:  Ther Adv Psychopharmacol       Date:  2015-12

6.  Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics.

Authors:  Mikail Weston; Teresa Kaserer; Angela Wu; Alexandre Mouravlev; Jenna C Carpenter; Albert Snowball; Samuel Knauss; Melanie von Schimmelmann; Matthew J During; Gabriele Lignani; Stephanie Schorge; Deborah Young; Dimitri M Kullmann; Andreas Lieb
Journal:  Sci Adv       Date:  2019-04-17       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.